PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

September 20, 2024

Study Completion Date

September 20, 2024

Conditions
DepressionBurnout, Professional
Interventions
DRUG

Psilocybin

Psilocybin is a classic psychedelic of medium duration that is well-tolerated and has a documented safety and efficacy record that makes it uniquely well-suited to the issues that arise in this participant population. Psilocybin has been described as an 'existential medicine' given patient testimonials as to its acute and lasting effects on interpersonal connection, ability to more deeply engage with meaningful activities and relationships, dramatic reductions in fear of death, and a renewed sense of well-being.

BEHAVIORAL

Mindfulness-Based Stress Reduction (MBSR)

Mindfulness-Based Stress Reduction (MBSR) is a well-established evidence-based mindfulness training program initially developed by Jon Kabat-Zinn that has been shown to reduce symptoms of depression, anxiety, and burnout. The 8-week MBSR curriculum provides training in formal meditation practices including body scan techniques, mindfulness meditation, and yoga. Mindfulness can be understood as the non-judgmental acceptance and investigation of present experience, including body sensations, internal mental states, thoughts, emotions, impulses and memories, in order to reduce suffering or distress and to increase well-being.

Trial Locations (1)

84108

Huntsman Mental Health Institute, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

Heffter Research Institute

OTHER

collaborator

Usona Institute

OTHER

lead

University of Utah

OTHER